Close

Mr Kevin Van Zandvoort

Research Fellow

United Kingdom

Epidemiologist and infectious disease modeller with a strong interest in disease transmission and vaccine strategies. Over ten years of experience in programming, statistical analysis, and web-development. My current research focusses on i) optimizing pneumococcal vaccination in humanitarian crises and ii) evaluating reduced dose pneumococcal vaccination strategies.

Affiliations

Department of Infectious Disease Epidemiology and Dynamics
Faculty of Epidemiology and Population Health

Centres

Centre for Mathematical Modelling of Infectious Diseases
Vaccine Centre
Health in Humanitarian Crises Centre

Teaching

I teach on Epidemiology and Control of Communicable Diseases (EPM301) and Mathematical Modelling of Infectious Diseases (EPM302) for the distance learning MSc Epidemiology, and on Health Data Management and Mathematical Modelling of Infectious Diseases on in-person MSc programmes. I supervise several MSc summer projects every year.

Selected Publications

Social contacts and other risk factors for respiratory infections among internally displaced people in Somaliland.
VAN ZANDVOORT, K; Bobe, MO; Hassan, AI; Abdi, MI; Ahmed, MS; Soleman, SM; Warsame, MY; Wais, MA; Diggle, E; MCGOWAN, CR; Satzke, C; Mulholland, K; Egeh, MM; Hassan, MM; Hergeeye, MA; EGGO, RM; CHECCHI, F; FLASCHE, S;
2022
Epidemics
The impact of population-wide rapid antigen testing on SARS-CoV-2 prevalence in Slovakia.
PAVELKA, M; Van-Zandvoort, K; ABBOTT, S; SHERRATT, K; Majdan, M; CMMID COVID-19 working group,; Inštitút Zdravotných Analýz,; Jarčuška, P; Krajčí, M; FLASCHE, S; FUNK, S;
2021
Science (New York, N.Y.)
Quantifying the impact of physical distance measures on the transmission of COVID-19 in the UK.
JARVIS, CI; VAN ZANDVOORT, K; Gimma, A; PREM, K; CMMID COVID-19 working group,; KLEPAC, P; Rubin, GJ; EDMUNDS, WJ;
2020
BMC medicine
Response strategies for COVID-19 epidemics in African settings: a mathematical modelling study.
VAN ZANDVOORT, K; JARVIS, CI; PEARSON, CA B; DAVIES, NG; CMMID COVID-19 working group,; RATNAYAKE, R; RUSSELL, TW; KUCHARSKI, AJ; JIT, M; FLASCHE, S; EGGO, RM; CHECCHI, F;
2020
BMC Medicine
Pneumococcal conjugate vaccine use during humanitarian crises.
VAN ZANDVOORT, K; CHECCHI, F; Diggle, E; EGGO, RM; Gadroen, K; Mulholland, K; MCGOWAN, CR; LE POLAIN DE WAROUX, O; RAO, VB; Satzke, C; FLASCHE, S;
2019
Vaccine
Efficacy of live oral rotavirus vaccines by duration of follow-up: a meta-regression of randomised controlled trials.
CLARK, A; VAN ZANDVOORT, K; FLASCHE, S; SANDERSON, C; Bines, J; Tate, J; Parashar, U; JIT, M;
2019
LANCET INFECTIOUS DISEASES
Mortality reduction benefits and intussusception risks of rotavirus vaccination in 135 low-income and middle-income countries: a modelling analysis of current and alternative schedules.
CLARK, A; Tate, J; Parashar, U; JIT, M; Hasso-Agopsowicz, M; Henschke, N; Lopman, B; VAN ZANDVOORT, K; Pecenka, C; FINE, P; SANDERSON, C;
2017
The Lancet Global Health
Antimicrobial resistance in bacterial wound, skin, soft tissue and surgical site infections in Central, Eastern, Southern and Western Africa: A systematic review and meta-analysis.
Monk, EJ M; Jones, TP W; Bongomin, F; Kibone, W; Nsubuga, Y; Ssewante, N; Muleya, I; Nsenga, L; Rao, VB; VAN ZANDVOORT, K;
2024
PLOS global public health
Pre-vaccination carriage prevalence of<i>Streptococcus pneumoniae</i>serotypes among internally displaced people in Somaliland
VAN ZANDVOORT, K; Ibrahim Hassan, A; Bobe, M; Pell, C; Ahmed, MS; Ortika, B; Ibrahim, S; Abdi, MI; Karim, M; EGGO, R; Yusuf, S; Hinds, J; Soleman, SM; Cummings, R; MCGOWAN, C; Mulholland, K; Hergeeye, MA; Satzke, C; CHECCHI, F; FLASCHE, S;
2024
medRxiv
Social contact patterns during the early COVID-19 pandemic in Norway: insights from a panel study, April to September 2020
Veneti, L; Robberstad, B; Steens, A; Forland, F; Winje, B; Vestrheim, D; Jarvis, C; Gimma, A; John Edmunds, W; Zandvoort, KV; De Blasio, BF;
2023
medRxiv
See more information